Pharmacogenomics in prescribing: building competence for safer, personalised care
Pharmacogenomics in prescribing: building competence for safer, personalised care
What is pharmacogenomics and why does it matter for prescribing? Learn how genetic variation influences medicines and why competence matters for UK prescribers.
Lead Author of the RPS Pharmacogenomic Resource to Support the Competency Framework for All Prescribers
This was published when the organisation was the Royal Pharmaceutical Society.
Pharmacogenomics — the study of how a person’s genetic makeup affects their response to medicines — is becoming increasingly relevant to prescribing practice. As genomic medicine develops across the UK, prescribers need the confidence to recognise when genetic factors may affect treatment decisions, medicine efficacy or the risk of adverse drug reactions.
The Royal Pharmaceutical Society’s (RPS) Pharmacogenomic Resource to Support the Competency Framework for All Prescribers is designed to support prescribers of all professional backgrounds in this evolving area of practice. Sitting alongside the RPS Competency Framework for All Prescribers, it provides structured guidance to help integrate pharmacogenomic principles into everyday prescribing practice safely and responsibly.
Why pharmacogenomics matters for prescribers
Genetic variations between people can affect how their bodies handle medicines. These differences can influence how quickly or slowly certain medicines are broken down, how well the medicine works and the risk of side effects. In certain clinical scenarios, pharmacogenomic testing can help inform medicine choice or dose selection.
For prescribers, competence in pharmacogenomics does not require specialist training in genomics. Rather, it involves:
Recognising when genetic factors may be clinically relevant
Understanding how to interpret validated information appropriately
Applying that information alongside clinical judgement
Incorporating insights into shared decision-making with patients
Pharmacogenomics aids professional clinical judgement by providing additional evidence to inform prescribing decisions, supporting medicines optimisation and improving patient safety.
Supporting confident implementation across the UK
The RPS Pharmacogenomic Resource is designed for prescribers at all stages of their careers, from those developing their prescribing practice to experienced prescribers expanding their scope.
It reflects the realities of implementation across the UK, including differences in access to pharmacogenomic testing and local service provision. By looking at prescribers’ competencies through a pharmacogenomic lens, the resource supports safe and accountable practice across care settings when pharmacogenomic testing is used.
The need for prescribers to have clear communication with patients remains central. Discussions about genetic testing and treatment options must be handled sensitively, with consideration of cultural and ancestral factors where appropriate. Accurate documentation and information sharing are essential to support continuity of care, particularly as genetic results remain constant even though interpretation may evolve over time.
Looking ahead
Pharmacogenomics is likely to become an increasingly integrated component of prescribing practice in the coming years. By using this resource, prescribers can ensure they are equipped to adapt safely as the use of personalised medicine continues to develop.
By strengthening the understanding of pharmacogenomics within existing prescribing competencies, this resource supports safer, more personalised and evidence-based care.
Black History Month: Why representation in healthcare matters
Black History Month is a time to celebrate our communities, honour our history and ask how we can make healthcare work better for everyone. At Black Sciensus, we are healthcare professionals creating clear, culturally relevant health information for Black and African communities. We believe knowledge is power. Our aim is simple: that anyone can visit our platform and find trusted, evidence-based health information that speaks to them, and that every healthcare professional can easily find the same for the Black and African patients they care for. Here is why that matters, and how pharmacy teams can help.
Understanding health inequalities
Some conditions affect Black communities more than others. Around 1 in 4 Black men in the UK will get prostate cancer, compared with about 1 in 8 men overall. High blood pressure and type 2 diabetes are also more common and can start at a younger age. Illness can look different too: rashes, eczema and jaundice can be harder to spot on darker skin.
Why representation matters
Awareness alone is not enough. A Black woman looking up information for herself or her child should feel that it speaks to her and her family. Even when medical advice is the same, seeing yourself in the pictures, examples and language builds trust and makes it more likely you will act on what you read. We have seen this first-hand — for example, one woman told us that our article on fibroids prompted her to get checked. She had lived with painful periods all her life and never thought anything of it. A young man told us that our mental health article helped him reach out for support. These are just two of the many stories we hear from our readers, and they remind us why we do what we do.
The role of pharmacy teams
Pharmacy teams are often the first place people turn to for health advice, with no appointment needed. A blood pressure check, a few unhurried minutes explaining a new medicine, or a gentle conversation about worries or herbal remedies can make a real difference. So can listening without judgement and having leaflets that reflect the people who walk through the door.
That support can reach beyond the counter too. Working with churches, mosques, schools and community groups helps share reliable information, challenge myths and reach people who might not otherwise come in.
Turning awareness into action
NHS England's Core20PLUS5 approach focuses on the communities most affected by health inequalities, and finding undiagnosed high blood pressure is one of its five priority areas. Across all areas of pharmacy practice, there is an important role to play in turning this ambition into action and helping to reduce health inequalities. This Black History Month, let us keep listening, learning and working together, so that every patient feels seen, heard and confident to make choices about their health. Better representation means better, fairer healthcare for all.
Find out more about Black Sciensus CIC.
Read more blogs.
Martina Aikon, one of the first pharmacists to qualify as an independent prescriber from registration, reflects on her first few weeks in practice and building confidence in her new role.